Estrogen News and Research

Latest Estrogen News and Research

Anastrozole drug: An effective new option for breast cancer prevention for postmenopausal women

Breast cancer incidence among postmenopausal women at high risk for developing the disease was significantly reduced by the antihormone therapy anastrozole, indicating that the drug may be an effective new option for breast cancer prevention for this group of women, according to initial results of a double-blind, randomized, placebo-controlled trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14. The study is being simultaneously published in the The Lancet.

13 Dec 2013

New test to help physicians identify patients with most lethal forms of triple-negative breast cancer

A new test has the potential to help physicians identify patients with the most lethal forms of triple-negative breast cancer, a disease which requires aggressive and innovative treatment.

12 Dec 2013

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) today announced that results from two studies of REVLIMID (lenalidomide) combinations in patients with diffuse large B-cell lymphoma (DLBCL) were presented at the American Society of Hematology annual meeting in New Orleans, La.

11 Dec 2013

High cholesterol fuels growth and spread of breast Cancer

Researchers at Duke Medicine conclude that high cholesterol may make breast cancer worse when they found that a byproduct of cholesterol functions like the hormone estrogen, leading to increases in the growth and spread of breast cancer. Studies have previously shown the link between obesity and breast cancer, but the exact cause of the increased risk had not been identified.

11 Dec 2013

Genetic deficiency in males can trigger hepatocellular carcinoma, type 2 diabetes

Michigan State University researchers have uncovered a genetic deficiency in males that can trigger the development of one of the most common types of liver cancer and forms of diabetes.

9 Dec 2013

Ventana now offers FDA-cleared image analysis and digital read application for IHC breast markers

Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration for the Companion Algorithm ER (SP1) image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry breast markers.

5 Dec 2013

New research shows that the brain can produce and release estrogen

A University of Wisconsin-Madison research team reports today that the brain can produce and release estrogen - a discovery that may lead to a better understanding of hormonal changes observed from before birth throughout the entire aging process.

5 Dec 2013

New studies offer hope to women who want to get sexual mojo back

For women, passing midlife can deal a blow to their sex drive. But two new studies just published online in Menopause, the journal of The North American Menopause Society, offer hope to women who want to get their sexual mojo back.

5 Dec 2013

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis will present updates on its broad cancer portfolio with more than 240 abstracts at the upcoming American Society of Hematology (ASH) annual meeting and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

4 Dec 2013

Synaptic health in the brain closely linked to cognitive decline

Age-related cognitive decline and changes in the nervous system are closely linked, but up until recently, they were thought to result from the loss of neurons in areas such as the prefrontal cortex, the part of the brain important in working memory.

3 Dec 2013

Researchers create computer algorithm to identify specific genes involved in breast cancer growth

Researchers from the University of Alberta and Alberta Health Services have created a computer algorithm that successfully predicts whether estrogen is sending signals to cancer cells to grow into tumours in the breast. By finding this hormone receptor, known as estrogen receptor positive, physicians can prescribe anti-estrogen drug therapies, improving patient outcomes.

3 Dec 2013

Elevated cholesterol is associated with breast cancer risk

A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, researchers at the Duke Cancer Institute report.

29 Nov 2013

Researchers show benefits from testosterone administration in hysterectomized women

Hysterectomy and oophorectomy (the removal of ovaries) are performed to treat various diseases in women, including cancer. These procedures are accompanied not only by a decline in estrogen but also testosterone levels in the blood.

27 Nov 2013

High intake of sugar-sweetened beverages reports increased risk of endometrial cancer

Postmenopausal women who consumed sugar-sweetened beverages were more likely to develop the most common type of endometrial cancer compared with women who did not drink sugar-sweetened beverages, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

25 Nov 2013

Research shows oral contraceptive use over three years could be a risk factor for glaucoma

Research presented today, at the 117th Annual Meeting of the American Academy of Ophthalmology in New Orleans, has found that women who have taken oral contraceptives for three or more years are twice as likely to suffer from glaucoma, one of the leading causes of blindness which affects nearly 60 million worldwide. The researchers caution gynecologists and ophthalmologists to be aware of the fact that oral contraceptives might play a role in glaucomatous diseases, and inform patients to have their eyes screened for glaucoma if they also have other risk factors.

19 Nov 2013

InControl Medical supports urinary incontinence awareness effort of Women's Health Foundation

According to a new survey endorsed by the Women's Health Foundation, a national nonprofit organization dedicated to bringing education, funding and research to the field of women's pelvic health, seven out of ten (69%) American women ages 45 or older may not recognize that incontinence may be a signal of a bladder health problem. To raise awareness of this issue among women everywhere, the Foundation has declared November to be Bladder Health Awareness Month.

16 Nov 2013

Women’s recovery from concussions may depend on menstrual cycle

How well a woman recovers from a concussion may depend on that time of the month.

14 Nov 2013

Research reveals unexpected roles that sex hormones may play in cognitive function

Research released today demonstrates unexpected roles that sex hormones may play in the cognitive function of females, including memory and interpreting social cues.

12 Nov 2013

Scientists study effect of diet complexity, estrogen hormone receptors on intestinal microbiota

Texas A&M University and University of North Carolina School of Medicine scientists have completed a study on the effect of diet complexity and estrogen hormone receptors on intestinal microbiota.

11 Nov 2013

Breast cancer drug appears to protect cells against UV radiation, inflammation

Exemestane, a synthetic steroid drug widely prescribed to fight breast cancers that thrive on estrogens, not only inhibits the production of the hormone, but also appears to protect cells throughout the body against damage induced by UV radiation, inflammation and other assaults, according to results of research by Johns Hopkins scientists.

8 Nov 2013

Estrogen News and Research

Latest Estrogen News and Research

Anastrozole drug: An effective new option for breast cancer prevention for postmenopausal women

New test to help physicians identify patients with most lethal forms of triple-negative breast cancer

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

High cholesterol fuels growth and spread of breast Cancer

Genetic deficiency in males can trigger hepatocellular carcinoma, type 2 diabetes

Ventana now offers FDA-cleared image analysis and digital read application for IHC breast markers

New research shows that the brain can produce and release estrogen

New studies offer hope to women who want to get sexual mojo back

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Synaptic health in the brain closely linked to cognitive decline

Researchers create computer algorithm to identify specific genes involved in breast cancer growth

Elevated cholesterol is associated with breast cancer risk

Researchers show benefits from testosterone administration in hysterectomized women

High intake of sugar-sweetened beverages reports increased risk of endometrial cancer

Research shows oral contraceptive use over three years could be a risk factor for glaucoma

InControl Medical supports urinary incontinence awareness effort of Women's Health Foundation

Women’s recovery from concussions may depend on menstrual cycle

Research reveals unexpected roles that sex hormones may play in cognitive function

Scientists study effect of diet complexity, estrogen hormone receptors on intestinal microbiota

Breast cancer drug appears to protect cells against UV radiation, inflammation

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Estrogen News and Research

Latest Estrogen News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in